作者：
Wei,Wang [1]
;
Esmeralda,Alvarado-Facundo [1]
;
Russell,Vassell [1]
;
Limone,Collins [2]
;
Rhonda E,Colombo [3]
;
Anuradha,Ganesan [4]
;
Casey,Geaney [5]
;
David,Hrncir [6]
;
Tahaniyat,Lalani [3]
;
Ana Elizabeth,Markelz [4]
;
Ryan C,Maves [5]
;
Bruce,McClenathan [3]
;
Katrin,Mende [7]
;
Stephanie A,Richard [4]
;
Christina,Schofield [5]
;
Srihari,Seshadri [8]
;
Christina,Spooner [9]
;
Gregory C,Utz [10]
;
Tyler E,Warkentien [11]
;
Min,Levine [4]
;
Christian L,Coles [5]
;
Timothy H,Burgess [9]
;
Maryna,Eichelberger [4]
;
Carol D,Weiss [5]
作者单位：
Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
[1]
Defense Health Agency- Immunization Healthcare Division, Falls Church, Virginia, USA.
[2]
Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
[3]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
[4]
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
[5]
Madigan Army Medical Center, Fort Lewis, Washington, USA.
[6]
Defense Health Agency- Immunization Healthcare Division Regional Office, Lackland AFB, Texas, USA.
[7]
Naval Medical Center, Portsmouth, Virginia.
[8]
Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
[9]
Division of Infectious Diseases, Naval Medical Center, San Diego, California, USA.
[10]
Defense Health Agency- Immunization Healthcare Division Regional Office, Ft. Bragg, North Carolina, USA.
[11]
Influenza Division, Centers for Disease Control and Prevention, Atlanta Georgia, USA.
[12]
主题词
成年人(Adult);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);血凝素糖蛋白类, 流感病毒(Hemagglutinin Glycoproteins, Influenza Virus);血凝素类(Hemagglutinins);人类(Humans);流感病毒A型, H3N2亚型(Influenza A Virus, H3N2 Subtype);流感疫苗(Influenza Vaccines);流感, 人(Influenza, Human);季节(Seasons)
DOI
10.1093/cid/ciaa1352
PMID
32898271
发布时间
2022-05-31
换一批
换一批
